Pharmacology & ToxicologybioRxivPreprint
Zoledronic acid targets the mevalonate pathway causing reduced cell recruitment and attenuation of pulmonary fibrosis
L. Tanner, J. Bergwik, R. K. V. Bhongir, A. Egesten
This study shows zoledronic acid reduces pulmonary fibrosis by targeting the mevalonate pathway, decreasing myofibroblast transition and immune cell recruitment in a mouse model.
DOI 10.1101/2021.12.01.470755